Cogent Biosciences, Inc. (COGT)
34.67
-2.42
(-6.52%)
USD |
NASDAQ |
Aug 28, 16:00
34.73
+0.06
(+0.17%)
After-Hours: 20:00
Cogent Biosciences Free Cash Flow : -309.24M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -309.24M |
| March 31, 2026 | -286.27M |
| December 31, 2025 | -266.00M |
| September 30, 2025 | -246.73M |
| June 30, 2025 | -234.65M |
| March 31, 2025 | -222.82M |
| December 31, 2024 | -208.36M |
| September 30, 2024 | -192.10M |
| June 30, 2024 | -177.92M |
| March 31, 2024 | -168.40M |
| December 31, 2023 | -156.42M |
| September 30, 2023 | -143.41M |
| June 30, 2023 | -143.07M |
| March 31, 2023 | -137.35M |
| December 31, 2022 | -125.50M |
| September 30, 2022 | -115.34M |
| Date | Value |
|---|---|
| June 30, 2022 | -92.86M |
| March 31, 2022 | -77.89M |
| December 31, 2021 | -60.48M |
| September 30, 2021 | -48.64M |
| June 30, 2021 | -43.63M |
| March 31, 2021 | -39.32M |
| December 31, 2020 | -35.85M |
| September 30, 2020 | -34.94M |
| June 30, 2020 | -34.86M |
| March 31, 2020 | -37.88M |
| December 31, 2019 | -41.55M |
| September 30, 2019 | -42.11M |
| June 30, 2019 | -39.58M |
| March 31, 2019 | -36.54M |
| December 31, 2018 | -33.04M |
| September 30, 2018 | -30.63M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Apogee Therapeutics, Inc. | -243.96M |
| Erasca, Inc. | -98.08M |
| Moderna, Inc. | -1.244B |
| Arrowhead Pharmaceuticals, Inc. | -75.11M |
| Oncolytics Biotech, Inc. | -26.53M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -77.27M |
| Cash from Investing (Quarterly) | 14.28M |
| Cash from Financing (Quarterly) | 2.955M |
| Free Cash Flow Per Share (Quarterly) | -0.4539 |
| Free Cash Flow to Equity (Quarterly) | -83.25M |
| Free Cash Flow to Firm (Quarterly) | -76.42M |
| Free Cash Flow Yield | -5.77% |